Copyright
©The Author(s) 2025.
World J Gastroenterol. Jul 21, 2025; 31(27): 107740
Published online Jul 21, 2025. doi: 10.3748/wjg.v31.i27.107740
Published online Jul 21, 2025. doi: 10.3748/wjg.v31.i27.107740
Table 5 Summary of significant transthoracic echocardiography findings, by study (continued)
| Ref. | LVESD (cm) | LVEDD (cm) | LVOT VTI (cm) | TAPSE (mm) | PASP (mmHg) | RWT |
| Ali et al[10] | 3.2 vs 2.8 [OR = 5.43 (1.44-24.50), P = 0.02] | 5.2 vs 4.6 [OR = 4.12 (1.51-13.47), P = 0.001] | ≥ 31 (OR = 1.27 (1.51-13.47) P = 0.001) | |||
| Alla et al[40] | 30 ± 6 [OR = 3.4 (4.0-32.4) P < 0.001] | 30 ± 6 [OR = 3.4 (4.4-1.9), P = 0.01] | ||||
| Venner et al[46] | 0.39 vs 0.34 [OR = 1.03 (1.02-1.30), P = 0.012] |
- Citation: Tomassoni DR, Schildkraut T, Ramachandran V, Cooke JC, Sawhney R. Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. World J Gastroenterol 2025; 31(27): 107740
- URL: https://www.wjgnet.com/1007-9327/full/v31/i27/107740.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i27.107740